Denosumab as an add-on Neoadjuvant Treatment (GeparX)

NCT02682693 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

780

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Female NOS
Tubular Breast Cancer Stage II
Mucinous Breast Cancer Stage II
Invasive Ductal Breast Cancer
HER2 Positive Breast Cancer
Inflammatory Breast Cancer
Tubular Breast Cancer Stage III

Interventions

DRUG: Denosumab
DRUG: nab-Paclitaxel
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Carboplatin
DRUG: Trastuzumab
DRUG: Pertuzumab

Sponsor

GBG Forschungs GmbH

Collaborators

[object Object]
[object Object]